Lexaria Bioscience Corp (LEXXW) — Cash Flow Reinvestment Rate

Latest as of November 2013: 0.37x

Lexaria Bioscience Corp (LEXXW) has a Cash Flow Reinvestment Rate of 0.37x as of November 2013, reinvesting $27.23K (capex $27.23K ) from operating cash flow of $74.27K. Check LEXXW operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.37x
(Capex + Investments) / Operating CF

Total Reinvested

$27.23K
Capex + Investments

Operating Cash Flow

$74.27K
USD

Capital Expenditures

$27.23K
USD

Lexaria Bioscience Corp Cash Flow Reinvestment Rate (2007–2014)

Historical reinvestment intensity for Lexaria Bioscience Corp across 6 annual periods. Explore LEXXW debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Lexaria Bioscience Corp (2007–2014)

Year-by-year capital reinvestment analysis for Lexaria Bioscience Corp. For live market cap and broader valuation context, see LEXXW stock market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2014 0.29x $91.61K $321.00K $91.61K ▲ +0.0%
2013 0.29x $91.61K $321.00K $91.61K ▲ +0.0%
2012 0.29x $91.61K $321.00K $91.61K ▼ -85.8%
2011 2.02x $274.13K $135.94K $274.13K ▼ -77.9%
2010 9.13x $1.00 Million $109.84K $1.00 Million ▼ -54.5%
2007 20.06x $582.43K $29.04K $582.43K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow